drugset / Trial / NCT07155525

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

NCT07155525

Phase 3 Recruiting 194 enrolled Minia University
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single-center, randomized controlled trial comparing the efficacy of pancreaticojejunostomy with modified N-butyl-2-cyanoacrylate(Glubran® 2) versus standard pancreaticojejunostomy without cyanoacrylate in preventing postoperative pancreatic fistula (POPF) in patients undergoing pancreaticoduodenectomy with soft pancreatic texture. The primary endpoint is the incidence of postoperative pancreatic fistula at 30 days post-surgery, as defined by the International Study Group on Pancreatic Fistula (ISGPF) criteria.Secondary outcomes include surgical complications and length of hospital stay. The study will enroll approximately 194 patients at a single center.

Timeline

Start
2025-09-15
Primary completion
2028-09-15
Completion
2028-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject N-butyl-2-cyanoacrylate Other / unclassified 0.5 ml Topical
Subject N-butyl-2-cyanoacrylate Other / unclassified 1 ml Topical
Subject N-butyl-2-cyanoacrylate Other / unclassified 2 ml Topical